Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M37.9Revenue (TTM) $M65.9Net Margin (%)-36.6Altman Z-Score-17.3
Enterprise Value $M14.3EPS (TTM) $-0.3Operating Margin %-37.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-36.6Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio9.2Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio9.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-188.2ROA % (ttm)-65.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-82.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M71.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with THLD

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

THLD is held by these investors:



THLD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fernandes Joel ASenior Vice President 2015-09-28Buy3,562$3.96-86.36view
JAEGER WILFRED EDirector 2015-02-18Buy25,000$3.75-85.6view
Davar NipunVice President 2014-10-13Buy3,000$2.99-81.94view
YOUNGER WILLIAM H JR10% Owner 2014-10-01Sell242,396$3.77-85.68view
WHITE JAMES N10% Owner 2014-10-01Sell239,538$3.77-85.68view
SWEET DAVID E10% Owner 2014-10-01Sell229,154$3.77-85.68view
Speiser Michael L10% Owner 2014-10-01Sell227,228$3.77-85.68view
SHEEHAN ANDREW T10% Owner 2014-10-01Sell230,352$3.77-85.68view
Pullara Samuel J III10% Owner 2014-10-01Sell226,657$3.77-85.68view
GAITHER JAMES C10% Owner 2014-10-01Sell231,287$3.77-85.68view

Press Releases about THLD :

Quarterly/Annual Reports about THLD:

News about THLD:

Articles On GuruFocus.com
Tuesday Pre-Market Insights: THLD, PLL, AOL, CALL May 12 2015 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 47,619 Shares Mar 15 2011 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 52,356 Shares Oct 06 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 20,000 Shares Jun 05 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Mar 30 2017
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Mar 29 2017
Threshold Pharmaceuticals posts 4Q loss Mar 27 2017
Threshold Pharmaceuticals posts 4Q loss Mar 27 2017
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 27 2017
Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results Mar 27 2017
[$$] Molecular Templates to Combine With Threshold Pharmaceuticals Mar 21 2017
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change... Mar 17 2017
Threshold Pharma to Merge with Molecular Templates Mar 17 2017
Threshold Pharmaceuticals and Molecular Templates Agree to Combine Mar 17 2017
Development costs to keep Merck KGaA profit flat this year Mar 09 2017
Development costs to keep Merck KGaA profit flat this year Mar 09 2017
Merck KGaA predicts stable adj EBITDA in 2017 Mar 09 2017
Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold... Jan 26 2017
Hurry! These 5 Stocks Are About to Break Out Explosively Jan 13 2017
Is Threshold Pharmaceuticals, Inc. (THLD) A Good Stock To Buy? Dec 12 2016
THRESHOLD PHARMACEUTICALS INC Financials Nov 15 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Nov 15 2016
Merck KGaA expects profit gain from lower development costs Nov 15 2016
Threshold Pharmaceuticals Reports Third Quarter Financial Results Nov 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)